ArticleBiology2026
Exploratory Transcriptomic, Genomic, Pharmacogenomic, and Cellular Evaluation of FKBP4 in Lung Adenocarcinoma.
Fangyu Wang, Pengfei Lyu, Weimin Chen, Huiquan Gu, Wenlong Han, Yaolong Yu, Chen Chen, Rui He, Qiang Liu
Abstract read
In one paragraphArticle in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Fangyu WangKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Pengfei LyuDepartment of Breast-Thoracic Tumor Surgery, Affiliated Nanhua Hospital, University of South China, Hengyang 421009, China.
Weimin ChenKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Huiquan GuKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Wenlong HanKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Yaolong YuKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Chen ChenSchool of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0003-2104-534X Rui HeKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.
Qiang LiuKey Laboratory of Tropical Translational Medicine of the Ministry of Education, School of Basic Medical Sciences, Hainan Medical University, Haikou 571199, China.ORCID 0000-0003-0602-7872 Funding
China Scholarship Council 202308460036Hainan Medical University XSTS2025166Hainan Medical University 2026 Innovation and Entrepreneurship Training Program for College Students X202611810060National Natural Science Foundation of China 82060851
6 · The paper itselfAbstract
FK506-binding protein 4 (FKBP4), also known as FKBP52, is an HSP90 co-chaperone associated with poor outcomes in lung adenocarcinoma (LUAD). We evaluated FKBP4 using TCGA-LUAD, cBioPortal, CellMiner, and H1299 cell data. Among 535 primary tumors, the 20 displayed
Indexed as
FKBP4H1299 cellslung adenocarcinomapharmacogenomicstranscriptomics
Identifiers
PMID42792605
PMCPMC13604572
What OpenQuestion holds
Textmetadata
Read underepoch 390